Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Scientific Reports|March 18, 2020
Area-specific economic status should be regarded as a vital factor affecting the occurrence, development and outcome of cervical cancerZichao Li, Haozhi Wu, Xiaowei Yi, et al.
Current Topics in Medicinal Chemistry|June 16, 2026
BMS-CTMC-2025-461Ubiquitin as a Putative Causal Immune Orchestrator in Initial COVID-19 Severity: A Mendelian Randomization and Multi-Omics StudyYueyue Wang, Sirui Cai, Yubo Sun, et al.
Biomedicines|January 25, 2025
TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung AdenocarcinomaFeiming Hu, Chenchen Hu, Yuanli He, et al.
Frontiers in Immunology|February 20, 2026
Multicenter real-world data on immunotherapy for R/M HNSCC from China: comprehensive analysis of efficacy and survival differences across diverse clinical backgrounds, and identification of predictive peripheral blood biomarkersFeifan Sun, Shasha Pu, Bingxin Hou, et al.
Vaccines|April 23, 2022
Comparative Immunoreactivity Analyses of Hantaan Virus Glycoprotein-Derived MHC-I Epitopes in VaccinationBaozeng Sun, Junqi Zhang, Jiawei Wang, et al.
Frontiers in Immunology|June 6, 2018
T Follicular Helper-Like Cells Are Involved in the Pathogenesis of Experimental Autoimmune EncephalomyelitisJun Guo, Cong Zhao, Fang Wu, et al.
International Journal of Molecular Medicine|June 29, 2021
miR‑29b suppresses proliferation and induces apoptosis of hepatocellular carcinoma ascites H22 cells via regulating TGF‑β1 and p53 signaling pathwayYan-Lu Liu, Wen-Hao Yang, Bao-Yi Chen, et al.
Cell Death & Disease|July 20, 2018
BAP31, a newly defined cancer/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progressionErle Dang, Shuya Yang, Chaojun Song, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 22, 2023
miR-145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYCChenchen Hu, Tianyue Liu, Wenxin Zhang, et al.
Cancer Medicine|November 19, 2020
MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathwayShuya Yang, Yuanjie Sun, Dongbo Jiang, et al.
Pageof 6